US Stock MarketDetailed Quotes

VKTX Viking Therapeutics

Watchlist
  • 75.380
  • -1.590-2.07%
Trading May 6 14:04 ET
8.31BMarket Cap-81934P/E (TTM)

About Viking Therapeutics Company

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Company Profile

SymbolVKTX
Company NameViking Therapeutics
Listing DateApr 29, 2015
Issue Price8.00
Founded2012
CEODr. Brian Lian, PhD
MarketNASDAQ
Employees27
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address9920 Pacific Heights Boulevard,Suite 350
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-704-4660
Websitehttp://www.vikingtherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Brian Lian, PhD
  • President, Chief Executive Officer and Director
  • 12.63M
  • Marianne Mancini
  • Chief Operating Officer
  • 3.51M
  • Greg S. Zante
  • Chief Financial Officer and Principal Accounting Officer
  • 3.50M
  • Charles A. Rowland, Jr,M.B.A.
  • Independent Director
  • 189.62K
  • Dr. S. Kathryn Rouan, PhD
  • Independent Director
  • 178.65K
  • Matthew W. Foehr
  • Independent Director
  • 169.37K
  • J. Matthew Singleton
  • Independent Director
  • 192.77K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg